Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

2

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Glucocorticoid receptor

2

Mineralocorticoid receptor

2

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

2

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1955

2

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Addison's disease

2

Salt-losing adrenogenital syndrome

2

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

2

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

2

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Fried, J.|Sabo, E.F.

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

2

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

2

CHEBI

2

ChEMBL

2

DAILYMED

2

DRUG BANK

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

SENSORY ORGANS

1

SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

CORTICOSTEROIDS FOR SYSTEMIC USE

1

OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS

1

OPHTHALMOLOGICALS

1

OTOLOGICALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION

1

CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION

1

CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Corticosteroids and antiinfectives in combination

1

Mineralocorticoids

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

FLUDROCORTISONE

U0476M545B

Export Data
Search for Structure

Status:

US Approved Rx (2024)

First approved in 1955

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Mineralocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Glucocorticoid receptor

Conditions:

Addison's disease

Salt-losing adrenogenital syndrome

Fludrocortisone acetate (approved as Florinef) is a synthetic adrenocortical steroid possessing very potent mineralcorticoid properties and high glucocorticoid activity. Main indications are Partial replacement therapy for primary and secondary adren...

ocortical insufficiency in Addison's disease and for the treatment of salt losing adrenogenital syndrome.

FLUDROCORTISONE ACETATE

V47IF0PVH4

Export Data
Search for Structure

Status:

US Approved Rx (2024)

First approved in 1955

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Mineralocorticoid receptor

Mineralocorticoid receptor

Glucocorticoid receptor

Glucocorticoid receptor

Conditions:

Addison's disease

Salt-losing adrenogenital syndrome

Fludrocortisone acetate (approved as Florinef) is a synthetic adrenocortical steroid possessing very potent mineralcorticoid properties and high glucocorticoid activity. Main indications are Partial replacement therapy for primary and secondary adren...

ocortical insufficiency in Addison's disease and for the treatment of salt losing adrenogenital syndrome.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1